Santen Sends Expert Researchers to US, Europe to Assess Candidate Compounds for In-licensing

Toshiaki Nishihata, director and executive corporate officer, US and Europe Business, and head of the Research and Development Division at Santen Pharmaceutical, announced at a recent business briefing that the company has dispatched expert researchers to the US and Europe...read more